Empresa Artemis Therapeutics Inc OTC Bulletin Board
Acciones
US04302Q1094
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Shimon Citron
CEO | Chief Executive Officer | 70 | 30/06/22 |
David Dana
DFI | Director of Finance/CFO | 60 | 26/07/22 |
Dana Wolf
CTO | Chief Tech/Sci/R&D Officer | 66 | 02/08/16 |
Haim Tabak
COO | Chief Operating Officer | 76 | 01/01/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Shimon Citron
CEO | Chief Executive Officer | 70 | 30/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 112 033 909 | 14 484 776 ( 12,93 %) | 0 | 12,93 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+11,60 % | 106 mil M | |
-4,68 % | 24,28 mil M | |
-0,82 % | 21,96 mil M | |
-10,12 % | 18,16 mil M | |
-42,12 % | 16,37 mil M | |
-17,47 % | 15,56 mil M | |
+2,77 % | 13,63 mil M | |
+34,58 % | 12,27 mil M | |
+77,64 % | 8873,08 M |